Metformin and Not Diabetes Influences the Survival of Resected Early Stage NSCLC Patients.

about

Metformin in Lung Cancer: Review of in Vitro and in Vivo Animal Studies.Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: A meta-analysis.

P2860

Q39290525-4A382A3A-AFAB-488A-8942-DA870F7B4A13 Q55177909-00B166CA-3AC4-4EF2-8EB0-34805C205C5F

P2860

Metformin and Not Diabetes Influences the Survival of Resected Early Stage NSCLC Patients.

Item

http://www.wikidata.org/entity/Q36131775

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Metformin and Not Diabetes Inf ...... ed Early Stage NSCLC Patients.

@ast

Metformin and Not Diabetes Inf ...... ed Early Stage NSCLC Patients.

@en

type

Item

label

Metformin and Not Diabetes Inf ...... ed Early Stage NSCLC Patients.

@ast

Metformin and Not Diabetes Inf ...... ed Early Stage NSCLC Patients.

@en

prefLabel

Metformin and Not Diabetes Inf ...... ed Early Stage NSCLC Patients.

@ast

Metformin and Not Diabetes Inf ...... ed Early Stage NSCLC Patients.

@en

P1476

Metformin and Not Diabetes Influences the Survival of Resected Early Stage NSCLC Patients

@en

P2093

Adrienne Groman

http://www.w3.org/2001/XMLSchema#string

Alison Meagher

http://www.w3.org/2001/XMLSchema#string

Graham W Warren

http://www.w3.org/2001/XMLSchema#string

Sai Yendamuri

http://www.w3.org/2001/XMLSchema#string

Todd Demmy

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2012

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

Metformin and reduced risk of cancer in diabetic patients

DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value.

Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.

Understanding the benefit of metformin use in cancer treatment.

Diabetes mellitus, fasting glucose, and risk of cause-specific death.

Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.

Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types.

Development and validation of a quantitative real-time polymerase chain reaction classifier for lung cancer prognosis.

P304

217-222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4172/1948-5956.1000275

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Samjot Dhillon

P577

2014-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26457130

http://www.w3.org/2001/XMLSchema#string

P921

metformin

P932

4596545

http://www.w3.org/2001/XMLSchema#string

Metformin and Not Diabetes Influences the Survival of Resected Early Stage NSCLC Patients.

about

P2860

P2860

Metformin and Not Diabetes Influences the Survival of Resected Early Stage NSCLC Patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932